Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Leggett & Platt | LEG | Nov 20, 2024 | 11.28 | -1.48 |
Leidos | LDOS | Nov 20, 2024 | 162.15 | +2.44 |
LeMaitre Vascular | LMAT | Nov 20, 2024 | 103.44 | -0.29 |
Lemonade | LMND | Nov 20, 2024 | 46.58 | +16.04 |
LendingClub | LC | Nov 20, 2024 | 15.11 | +0.27 |
LendingTree | TREE | Nov 20, 2024 | 42.99 | +0.12 |
Lendway | LDWY | Nov 20, 2024 | 3.62 | -2.43 |
Lennar A | LEN | Nov 20, 2024 | 168.23 | -0.31 |
Lennar B | LEN-B | Nov 20, 2024 | 158.85 | -0.30 |
Lennox International | LII | Nov 20, 2024 | 625.35 | +0.28 |
LENSAR | LNSR | Nov 20, 2024 | 7.28 | -2.54 |
LENZ Therapeutics | LENZ | Nov 20, 2024 | 33.91 | -2.14 |
Leonardo DRS | DRS | Nov 20, 2024 | 34.96 | -0.43 |
Lesaka Technologies | LSAK | Nov 20, 2024 | 5.30 | +4.74 |
Leslies | LESL | Nov 20, 2024 | 2.76 | -4.17 |
Levi Strauss & Co A | LEVI | Nov 20, 2024 | 15.80 | -1.19 |
Lexaria Bioscience | LEXX | Nov 20, 2024 | 2.20 | +1.38 |
Lexeo Therapeutics | LXEO | Nov 20, 2024 | 6.12 | +1.66 |
Lexicon Pharmaceuticals | LXRX | Nov 20, 2024 | 0.81 | -8.34 |
LexinFintech ADR | LX | Nov 20, 2024 | 3.33 | +3.42 |
LG Display ADR | LPL | Nov 20, 2024 | 3.46 | -1.70 |
LGI Homes | LGIH | Nov 20, 2024 | 101.79 | +0.62 |
LGL Group | LGL | Nov 20, 2024 | 6.04 | +0.23 |
Li Auto ADR | LI | Nov 20, 2024 | 22.78 | -1.77 |
Li Bang International | LBGJ | Nov 20, 2024 | 3.50 | 0.00 |
Li-Cycle | LICY | Nov 20, 2024 | 2.11 | -8.26 |
Liberty Allstar Equity Fund | USA | Nov 20, 2024 | 7.17 | 0.00 |
Liberty Allstar Growth Fund | ASG | Nov 20, 2024 | 5.68 | +0.35 |
Liberty Broadband A | LBRDA | Nov 20, 2024 | 86.87 | +0.95 |
Liberty Broadband A Pref | LBRDP | Nov 20, 2024 | 23.84 | -0.04 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.